Mirum Pharmaceuticals (NASDAQ:MIRM) PT Raised to $44.00 at Robert W. Baird
Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its price objective raised by stock analysts at Robert W. Baird from $39.00 to $44.00 in a report released on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s target price would suggest a potential upside of 9.95% from the […]
More Stories
Main Street Capital Co. (MAIN) to Issue Dividend of $0.30 on September 27th
Main Street Capital Co. (NYSE:MAIN – Get Free Report) declared a dividend on Thursday, September 19th, investing.com reports. Shareholders of...
ReShape Lifesciences Stock Set to Reverse Split on Monday, September 23rd (NASDAQ:RSLS)
ReShape Lifesciences Inc. (NASDAQ:RSLS – Free Report) shares are scheduled to reverse split on the morning of Monday, September 23rd....
Shoe Carnival, Inc. (SCVL) to Issue Quarterly Dividend of $0.14 on October 21st
Shoe Carnival, Inc. (NASDAQ:SCVL – Get Free Report) declared a quarterly dividend on Tuesday, September 17th, Zacks reports. Investors of...
Shoe Carnival, Inc. (SCVL) to Issue Quarterly Dividend of $0.14 on October 21st
Shoe Carnival, Inc. (NASDAQ:SCVL – Get Free Report) declared a quarterly dividend on Tuesday, September 17th, Zacks reports. Investors of...
UN chief strongly condemns Mali terrorist attack
UN Secretary-General António Guterres has called for accountability following a “despicable” terrorist attack in Mali this week, his Spokesperson said...
Whole generation of children ‘lost’ amid ongoing Gaza war, UNICEF warns
Last October’s terror attacks by Hamas and other Palestinian armed groups on Israeli communities marked a devastating day for children,...